热门资讯> 正文
STAAR Surgical推动与Alcon的全现金合并
2025-09-27 02:26
- STAAR Surgical Company (NASDAQ:STAA) said in a presentation today that its $28.00 per share all-cash merger with Alcon provides its stockholders compelling, certain, cash value at a significant premium across multiple measures.
- It represents a 51% premium to STAAR’s closing stock price on August 4, 2025.
- STAAR’s second largest active stockholder, Soleus Capital Master is supportive of the merger and intends to vote in favor absent a material change in circumstances.
- “If the Alcon merger does not move forward, we believe STAAR’s valuation will fall substantially, exposing stockholders to significant risk. The day prior to the announcement of the Alcon merger, STAAR’s stock closed at $18.49 per share following a more than 50% stock price decline in the prior year," Stephen Farrell, CEO of STAAR, said,
- STAA is +0.299065% to $26.83
- Source: Press Release
More on STAAR Surgical
- STAAR Surgical: Takeover Offer Comes At A Significant Premium
- Staar Surgical urges shareholders to back Alcon merger as “window shop” period ends
- STAAR Surgical's largest holder to vote against Alcon bid
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
